A Disruptive Approach to Characterization of mAb Charge Variants
Rapidly assess the impact of cell culture conditions on mAb quality and production.
Biopharmaceutical product development is all about product knowledge, whether it be writing a regulatory submission, investigating unexpected results, or performing extended characterization.
In this webinar, we will discuss a new strategy to dramatically simplify charge variant characterization. Discover how you can gain multiple pieces of critical information early in process development as well as:
- Identify glycation at the intact protein level with the Intabio ZT system
- Maintain separation resolution between icIEF and mass spectrometry
- Implement icIEF/UV-MS during cell culture process development
Keynote Speaker
Greg Adams PhD
Senior Director
FujiFilm Diosynth Biotechnologies
Interested in sponsoring this webinar? Contact our friendly sales team here.
Watch this Webinar for FREE Below
Information you provide will be shared with the sponsors for this content.
Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
